July 10, 2026 Agilon Health Inc. Reports Impressive ACO REACH Model Results for 2024 Performance Year Agilon Health Inc. reported $229 million in gross savings for its ACOs under the REACH model for 2024, marking a 13.6% savings rate. The initiative emphasizes improved senior care and 96% average quality scores, showcasing Agilon's commitment to healthcare efficiency.
July 07, 2026 Agilon Health Inc. to Announce Second Quarter 2026 Financial Results Agilon Health Inc. will announce its second quarter 2026 financial results on August 5, followed by a conference call at 4:30 p.m. ET. The company emphasizes value-based healthcare and partnerships with primary care physicians to enhance patient care.
June 09, 2026 Agilon Health Inc. Set to Engage Investors at Upcoming Conferences Agilon Health Inc. will participate in two key investor conferences, discussing its innovative approach to value-based care and its commitment to empowering physicians. The events aim to provide insights into Agilon's strategies for transforming healthcare delivery.
May 06, 2026 Agilon Health Inc. Reports Q1 2026 Results: A Mixed Bag of Challenges and Opportunities Agilon Health Inc. reported a mixed Q1 2026, with a 7% revenue decline but a significant rise in net income. The company faces challenges, including a drop in membership, yet remains focused on enhancing healthcare through innovative models under new CEO Tim O'Rourke.
May 06, 2026 Agilon Health Reports Strong First Quarter 2026 Results and Raises Full-Year Guidance Agilon Health reported strong financial results for Q1 2026, with increased profitability metrics despite a decline in membership. The company raised its full-year guidance and announced a leadership transition to enhance strategic execution.
April 27, 2026 Agilon Health Appoints Tim O’Rourke as New CEO Agilon Health has appointed Tim O’Rourke as its new CEO, succeeding Ronald A. Williams. O’Rourke brings over 25 years of healthcare leadership experience, aiming to enhance value-based care and empower primary care physicians across the nation.
April 06, 2026 Agilon Health Inc. Announces First Quarter 2026 Financial Results Release Date Agilon Health Inc. is set to release its Q1 2026 financial results on May 6, followed by a conference call at 4:30 p.m. ET. The company aims to provide stakeholders with insights into its performance and future strategies.
March 18, 2026 Agilon Health Inc. Announces Reverse Stock Split to Boost Stock Price and Market Appeal Agilon Health Inc. has announced a 1-for-25 reverse stock split to enhance its stock market appeal and meet NYSE compliance. This strategic move aims to elevate the stock price and attract more investors, with the split effective on March 30, 2026.
March 02, 2026 Agilon Health Inc. Faces Class Action Deadline Amid Securities Law Allegations Agilon Health Inc. is facing a federal securities class action due to allegations of misleading financial guidance and overstated financial conditions. Investors must act by March 2, 2026, to participate. The company's stock has already suffered a significant decline following the allegations.
February 25, 2026 Agilon Health Inc. Reports Year-End Financial Results: A Pivotal Transition Ahead Agilon Health Inc. reported a challenging fiscal year 2025 with significant losses and a membership decline. Despite these setbacks, the company is optimistic about its transformation initiatives and provides promising guidance for 2026.
February 25, 2026 Agilon Health Inc. Reports Challenging 2025 Annual Results Amidst Strategic Transitions Agilon Health Inc. reported a challenging 2025, with declines in Medicare Advantage membership and revenue, resulting in increased losses. The company's operational struggles stem from partnership exits, prompting a need for strategic realignment to restore stakeholder confidence.
February 17, 2026 Agilon Health Inc. Set to Showcase Innovations at Upcoming Conferences Agilon Health, Inc. will participate in three major healthcare conferences in March 2026, focusing on innovation and value-based care. Investors can access live webcasts and replays to stay informed about the company's strategic initiatives.
January 27, 2026 Agilon Health Inc. Faces Legal Challenges as Investors Seek Justice Agilon Health Inc. is facing a federal securities class action lawsuit due to misleading financial disclosures and leadership changes in 2025. Investors have until March 2, 2026, to apply as lead plaintiffs. The lawsuit highlights the importance of transparency in corporate governance.
January 22, 2026 Agilon Health Inc. Sets Date for Financial Results Release Agilon Health Inc. will announce its financial results for Q4 and full year 2025 on February 25, 2026. A conference call will follow at 4:30 p.m. ET to discuss the results and future outlook.
January 20, 2026 Agilon Health Inc. Faces Class Action Lawsuit: Robbins LLP Urges Shareholders to Act Agilon Health, Inc. is facing a class action lawsuit from Robbins LLP for allegedly misleading investors about its 2025 business prospects. Following disappointing financial results and leadership changes, shareholders are encouraged to participate in the lawsuit before the March 2, 2026 deadline.
January 16, 2026 Agilon Health Inc. Faces Securities Fraud Lawsuit Amid Leadership Changes and Missed Financial Targets Agilon Health Inc. is facing a class action lawsuit for allegedly misleading investors about its business prospects, coinciding with a significant leadership change. The company's stock plummeted after disappointing financial results and the suspension of guidance for 2025, raising concerns among shareholders.
January 15, 2026 Agilon Health Inc. Faces Class Action Lawsuit Amid Leadership Changes and Financial Setbacks Agilon Health Inc. is facing a class action lawsuit due to significant shareholder losses linked to leadership changes and misleading financial statements. Investors are urged to act before the March 2, 2026 deadline to participate in the lawsuit.
January 15, 2026 Agilon Health Inc. Under Scrutiny: Shareholder Rights Firm Launches Investigation Halper Sadeh LLC has initiated an investigation into Agilon Health Inc. over possible fiduciary breaches by its leadership. Shareholders are urged to participate in advocating for corporate governance reforms and to explore their rights for potential legal relief.
January 14, 2026 Securities Fraud Class Action Filed Against Agilon Health Inc. Agilon Health Inc. is facing a securities fraud class action due to misleading statements and significant stock declines following leadership changes. Investors have until March 2, 2026, to join the lawsuit.
January 13, 2026 Agilon Health Inc. Faces Class Action Lawsuit Amid Securities Fraud Allegations Agilon Health Inc. is under scrutiny as a class action lawsuit has been filed due to allegations of misleading statements and financial failures. Investors are encouraged to participate and seek legal guidance ahead of the March 2026 deadline.
January 13, 2026 Agilon Health Inc. Faces Class Action Lawsuit Over Securities Fraud Allegations Agilon Health Inc. is facing a class action lawsuit filed by investors alleging securities fraud due to misleading statements from executives and a sudden leadership change. Following the departure of its CEO, the company's stock price plummeted, raising concerns about corporate governance and transparency. Affected shareholders are advised to file claims promptly.
January 12, 2026 Agilon Health Inc. Faces Class Action Lawsuit Amidst Financial Challenges Agilon Health Inc. is under a securities class action lawsuit due to allegations of misleading financial statements and a significant leadership shakeup. Following a drastic stock decline, investors are encouraged to be proactive and understand the lawsuit's potential impact.
January 08, 2026 Agilon Health Inc. Faces Securities Fraud Investigation Amid Leadership Turmoil Agilon Health Inc. is currently under investigation for potential securities fraud following the unexpected departure of its CEO and disappointing financial results. The company's stock plummeted, raising concerns among investors about its future stability and potential legal claims.
January 08, 2026 Securities Fraud Investigation Launched Into Agilon Health Inc. Agilon Health Inc. is under investigation for potential securities law violations following a leadership shake-up and disappointing financial results. Investors who suffered losses are encouraged to seek legal counsel to explore their options for recovery.
January 08, 2026 Agilon Health Inc. Faces Securities Fraud Investigation: A Closer Look at the Recent Developments Agilon Health Inc. is under investigation for securities fraud following the sudden exit of its CEO and disappointing financial results. Investors are urged to consider their rights amid significant stock decline and potential legal claims.
January 05, 2026 Agilon Health Inc. Under Fire: Investigations and Class Action Lawsuit Loom Agilon Health Inc. faces serious allegations of misleading investors and violating securities laws, prompting an investigation and class action lawsuit. Affected shareholders must act by March 2, 2026, to appoint a lead plaintiff as the company’s stock value plummets amid these revelations.
January 05, 2026 Agilon Health Inc. Faces Class Action Lawsuit Over Securities Law Violations Agilon Health, Inc. is embroiled in a class action lawsuit for alleged securities law violations, with claims of misleading statements impacting investors during the class period. Shareholders are urged to consider joining the case for potential recovery, with a participation deadline approaching.
January 04, 2026 Agilon Health Inc. Faces Securities Fraud Lawsuit: Investors Urged to Act Agilon Health Inc. is facing a class action lawsuit for alleged securities fraud, claiming misleading financial statements harmed investors. The Schall Law Firm is urging affected shareholders to join the lawsuit before the March 2, 2026 deadline to potentially recover losses.
December 31, 2025 Agilon Health Inc. Faces Class Action Lawsuit Amidst Leadership Changes and Disappointing Financials Agilon Health Inc. is facing a class action lawsuit due to allegations of misleading financial guidance during a period of leadership changes. Following the resignation of its CEO and disappointing financial results, the company's stock plummeted, raising concerns among investors. Robbins LLP is inviting affected shareholders to join the class action as they navigate this turbulent situation.
December 31, 2025 Agilon Health Inc. Faces Securities Class Action Lawsuit Amidst Controversial Guidance Agilon Health, Inc. is embroiled in a securities class action lawsuit alleging misleading statements about its financial guidance. The suit claims that management issued unattainable forecasts, resulting in significant investor losses. The case could have serious implications for the company’s reputation and financial stability.
November 12, 2025 Agilon Health to Showcase Insights at the 8th Annual Evercore Healthcare Conference Agilon Health will participate in the 8th Annual Evercore Healthcare Conference on December 2, 2025, showcasing their commitment to value-based care. The management team will engage in a fireside chat, and a live webcast will be available for wider audience access.
November 07, 2025 Agilon Health Faces NYSE Non-Compliance Notice: A Look at the Implications Agilon Health has received a non-compliance notice from the NYSE due to its stock trading below $1.00. The company plans a reverse stock split to address this issue. Despite the notice, Agilon reassures stakeholders that operations remain stable as they work toward compliance.
November 04, 2025 Agilon Health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook Agilon Health reported its Q3 2025 results, showing a slight revenue decrease and a net loss of $110 million. The company is focused on enhancing operational efficiency while navigating the healthcare landscape, projecting a revenue range of $5.81 to $5.83 billion for the full year.
November 04, 2025 Agilon Health Inc. Reports Q3 2025 Results: A Mixed Picture Amidst Leadership Changes Agilon Health Inc. reported a mixed financial performance for Q3 2025, with a decrease in Medicare Advantage members and total revenue, alongside leadership transitions. Despite these challenges, the company is implementing strategic initiatives aimed at improving operational efficiency and financial stability.
October 27, 2025 Agilon Health Inc. Faces Scrutiny as Halper Sadeh LLC Investigates Potential Breaches of Fiduciary Duties Halper Sadeh LLC is investigating Agilon Health Inc. for potential breaches of fiduciary duties by its leaders. The firm encourages shareholders to advocate for corporate governance reforms and explore legal options to protect their investments.
October 17, 2025 Agilon Health Inc. Faces Securities Class Action Investigation Amidst Financial Turmoil Agilon Health, Inc. is under investigation for potentially misleading financial disclosures that led to a 51.5% stock drop. Investors can join a class action to seek compensation for losses. The Rosen Law Firm is leading the charge for affected shareholders.
October 09, 2025 Agilon Health Inc. Faces Securities Class Action Investigation Amidst Financial Turmoil Agilon Health Inc. is facing a securities class action investigation due to allegations of misleading financial information, resulting in a 51.5% stock drop. The Rosen Law Firm is encouraging affected investors to explore compensation options through a class action lawsuit.
October 06, 2025 Agilon Health Inc. Announces Q3 2025 Financial Results Release Date Agilon Health Inc. is set to release its Q3 2025 financial results on November 4, 2025. The announcement will be followed by a conference call providing insights into the company's performance and future strategies.
September 26, 2025 Agilon Health Faces Continued Scrutiny Amid Ongoing Investigation Agilon Health is under investigation led by Kahn Swick & Foti after a significant financial setback and a subsequent securities class action lawsuit. The company faces intense scrutiny over its leadership changes and disclosure practices, raising concerns for shareholders. KSF is seeking information from investors affected by these challenges.
August 04, 2025 Agilon Health Inc. Reports Challenging Q2 2025 Results Amidst Strategic Shifts Agilon Health Inc. faced a tumultuous Q2 2025, reporting a 6% revenue decline and a net loss of $104 million. The company is focusing on strategic initiatives to enhance operational efficiency and maintain long-term partnerships with primary care physicians.
May 06, 2025 Agilon Health Inc. Reports Q1 2025 Financial Results: A Mixed Bag Amidst Challenges Agilon Health Inc. reported mixed results for Q1 2025, facing challenges with a decline in Medicare Advantage membership and revenue. However, the company achieved a net income turnaround and remains committed to enhancing care quality and operational efficiency amidst ongoing healthcare complexities.
May 06, 2025 Agilon Health Reports First Quarter 2025 Results: A Mixed Performance Amid Market Challenges Agilon Health's Q1 2025 results reflect a decline in membership and revenue, yet a notable recovery in net income. The company remains optimistic about its Total Care Model and future growth despite market challenges.
April 04, 2025 Agilon Health Inc. to Showcase Innovations at BofA Securities 2025 Health Care Conference Agilon Health Inc. will showcase its innovative healthcare approaches at the BofA Securities 2025 Health Care Conference on May 14. The firm emphasizes value-based care and physician empowerment, aiming to transform healthcare delivery for senior patients.
March 25, 2025 Agilon Health Inc. Schedules First Quarter 2025 Financial Results Announcement Agilon Health, Inc. will announce its Q1 2025 financial results on May 6, 2025, followed by a conference call at 4:30 PM ET. The company focuses on empowering physicians and enhancing value-based care for senior patients in over 30 communities.
February 25, 2025 Agilon Health Inc. Reports Robust Growth Despite Financial Challenges in 2024 Agilon Health Inc. reported a 40% revenue increase in 2024, reaching $6.06 billion, despite facing rising net losses and declining profit margins. The company aims to transform healthcare for seniors while navigating legal and financial challenges.
February 25, 2025 Agilon Health Reports Robust Growth Amid Challenges in Medicare Advantage Market Agilon Health, Inc. reported strong financial results for 2024, with a 44% increase in revenue and a 36% growth in Medicare Advantage membership. Despite facing profitability challenges, the company remains committed to enhancing healthcare delivery through strategic improvements.
February 21, 2025 Agilon Health Inc. to Participate in TD Cowen’s 45th Annual Health Care Conference Agilon Health Inc. will participate in the 45th Annual TD Cowen Healthcare Conference on March 5, 2025. The event highlights Agilon's commitment to transforming healthcare through a value-based model and engaging with investors.
February 10, 2025 Agilon Health Inc. Announces Fourth Quarter and Full Year 2024 Financial Results Release Date Agilon Health is set to release its financial results for Q4 and the full year of 2024 on February 25, 2025, followed by a conference call for stakeholders. The company continues to focus on empowering physicians and transforming healthcare delivery in the U.S.
January 25, 2025 SWOT Analysis of Agilon Health Inc. in 2025 This article provides a comprehensive SWOT analysis of Agilon Health Inc. as of 2025, highlighting its strengths in partnerships and growth, weaknesses like financial instability, opportunities in market expansion, and threats from competition. Understanding these elements allows stakeholders to gauge the company's strategic positioning.
November 07, 2024 Agilon Health Inc. Reports Q3 2024: A Mixed Bag of Growth and Losses Agilon Health Inc. reports a 28% revenue increase to $1.5 billion in Q3 2024, but also faces significant losses, raising concerns about sustainability. Despite a 37% growth in membership, the company struggles with rising medical expenses and operational challenges.
August 06, 2024 Agilon Health Inc. Reports Mixed Results in Q2 2024 Financials Agilon Health's Q2 2024 results show significant growth in Medicare Advantage membership and revenue, but rising medical expenses have led to increased net losses. The company aims to enhance operational efficiency while navigating these challenges in the evolving healthcare landscape.
May 07, 2024 Agilon Health Inc. Reports Robust Growth in Q1 2024 Despite Net Loss Agilon Health Inc. showcased impressive growth in Q1 2024 with a 43% increase in Medicare Advantage members and a 52% revenue surge to $1.6 billion. Despite a net loss due to rising expenses, the company continues to expand its operations in the healthcare sector.
